FKBP5 polymorphisms and antidepressant response in geriatric depression.
FKBP5 polymorphisms and antidepressant response in geriatric depression.
复制标题
DOI:
10.1002/ajmg.b.31019
复制
发表时间:
2010-03-05
影响因子:
2.8
通讯作者:
Murphy, Greer M., Jr.
中科院分区:
文献类型:
--
作者:
Sarginson, Jane E.;Lazzeroni, Laura C.;Ryan, Heather S.;Schatzberg, Alan F.;Murphy, Greer M., Jr.
Genetic variation at the FKBP5 locus has been reported to affect clinical outcomes in patients treated with antidepressant medications in several studies. However, other reports have not confirmed this association. FKBP5 may regulate the sensitivity of the hypothalamic–pituitary–adrenal axis. We tested two FKBP5 single nucleotide polymorphisms (rs1360780 and rs3800373) in a sample of 246 geriatric patients treated for 8 weeks in a double-blind randomized comparison trial of paroxetine and mirtazapine. These two polymorphisms had previously been reported to predict efficacy in depressed patients treated with selective serotonin reuptake inhibitors such as paroxetine, and those treated with mirtazapine, an agent with both serotonergic and noradrenergic actions. However, we found no significant associations between these FKBP5 genetic variants and clinical outcomes. Neither mean Hamilton Depression Rating Scale scores nor time to remission or response were predicted by FKBP5 genetic variation. These results suggest that FKBP5 is unlikely to play a major role in determining antidepressant treatment outcomes in geriatric patients.
登录
查看更多内容
影响因子:
2.1
作者:
Kirchheiner, Julia;Lorrh, Rainer;Brockmdller, Juergen
通讯作者:
Brockmdller, Juergen
影响因子:
120.7
作者:
Binder, Elisabeth B.;Bradley, Rebekah G.;Ressler, Kerry J.
通讯作者:
Ressler, Kerry J.
影响因子:
30.8
作者:
Binder, EB;Salyakina, D;Muller-Myhsok, B
通讯作者:
Muller-Myhsok, B
影响因子:
4.4
作者:
Zhang, Xinyu;Clark, Abbot F.;Yorio, Thomas
通讯作者:
Yorio, Thomas
DOI:
10.1097/00005072-199712000-00001
发表时间:
1997-12-01
影响因子:
3.2
作者:
Mrak, RE;Griffin, WST;Graham, DI
通讯作者:
Graham, DI